DBV Technologies SA (DBVT)
13.42
-0.40
(-2.89%)
USD |
NASDAQ |
Sep 01, 16:00
13.55
+0.13
(+0.97%)
After-Hours: 20:00
DBV Technologies Cash from Operations (Annual) : -121.56M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -121.56M |
| December 31, 2024 | -104.29M |
| December 31, 2023 | -79.65M |
| December 31, 2022 | -55.67M |
| December 31, 2021 | -103.90M |
| December 31, 2020 | -165.61M |
| December 31, 2019 | -148.32M |
| December 31, 2018 | -161.18M |
| December 31, 2017 | -128.94M |
| Date | Value |
|---|---|
| December 31, 2016 | -65.86M |
| December 31, 2015 | -29.68M |
| December 31, 2014 | -27.27M |
| December 31, 2013 | -17.60M |
| December 31, 2012 | -13.40M |
| December 31, 2011 | -8.525M |
| December 31, 2010 | -5.901M |
| December 31, 2009 | -4.209M |
| December 31, 2008 | -5.731M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Cellectis SA | -40.14M |
| Akari Therapeutics Plc | -10.59M |
| EDAP TMS SA | -- |
| Autolus Therapeutics Plc | -284.23M |
| Evaxion AS | -6.645M |